Though the introduction of psychotropic medication for the treatment of depression and anxiety was first greeted by the psychoanalytic community with overt opposition, in recent years the belief that medication and psychoanalysis are incompatible is being reconsidered. A study at the Columbia University Center for Psychoanalytic Training and Research showed that in 29% of candidate training cases medication was used in combination with psychoanalysis. In most cases the indication for medication was a diagnosis of depression, and an antidepressant was prescribed. The implication of these data with respect to the impact of medication on analytic process and candidate training is discussed.
Get full access to this article
View all access options for this article.
References
1.
Adelman, S. A. (1985). Pills as transitional objects: a dynamic understanding of the use of medication in psychotherapy. Psychiat., 48:246–253.
2.
Cooper, M. (1985). Will neurobiology influence psychoanalysis? Amer. J. Psychiat., 142:139–1402.
3.
Donovan, S. J. & Rosse, S. P. (in press). Medication use during psychoanalysis: a survey. J. Clin. Psychiat.
4.
Esman, A. H. (1989). Psychoanalysis and general psychiatry: obsessive compulsive disorder as paradigm. J. Amer. Psychoanal. Assn., 37:319–336.
5.
Gutheil, T. G. (1982). The psychology of psychopharmacology. Bull. Mennings Clin., 46:321–330.
6.
Hausner, R. (1985-1986). Medication and transitional phenomena. Int. J. Psychoanal. Psychother., 11:375–398.
7.
Kantor, S. J. (1989). Transference and the beta adrenergic receptor: a case presentation. Psychiat., 52:107–115.
8.
Kantor, S. J. (1993). Analyzing a rapid cycler: can the transference keep up? In Psychotherapy and Medication: A Dynamic Integration, ed. M. Schachter. Northvale, NJ: Aronson, pp. 291–311.
9.
Ostow, M. (1962). Drugs in Psychoanalysis and Psychotherapy. New York: Basic Books.
10.
Roose, S. P. (1990). The use of medication in combination with psychoanalytic psychotherapy or psychoanalysis. In Psychiatry, Vol. 1, ed. R. Michels. Philadelphia: Lippincott, pp. 1–8.
11.
Roose, S. P. (in press). Does anxiety obstruct or motivate treatment? when to talk, when to prescribe and when to do both. In Anxiety: Symptoms and Signals, ed. S. P. Roose & R. A. Glick. Hillsdale, NJ: Analytic Press.
12.
Sarwer-Foner, G. J. (1960). The Dynamics of Psychiatric Drug Therapy. Springfield, IL: Charles C Thomas.
13.
Wylie, H. W. & Wylie, M. L. (1987). An effect of pharmacotherapy on the psychoanalytic process: case report of a modified analysis. Amer. J. Psychiat., 144:489–492.
